Holdings

Ikarian Capital, LLC

As of Sep 30, 2026, Ikarian Capital, LLC reported 118 positions worth US$472M. Largest: Kodiak Sciences Inc, Abivax SA and Vaxcyte, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Kodiak Sciences Inc533KUS$50.5M−527KSep 30, 2026
Abivax SA286KUS$28.4M−42,726Sep 30, 2026
Vaxcyte, Inc.400KUS$22.8M+11,783Sep 30, 2026
Arcus Biosciences, Inc.735KUS$19M+230KSep 30, 2026
Celldex Therapeutics, Inc.519KUS$16.8M+40,000Sep 30, 2026
Amylyx Pharmaceuticals, Inc.561KUS$16.3M+444KSep 30, 2026
Vera Therapeutics, Inc.400KUS$12.9M+90,000Sep 30, 2026
Alto Neuroscience, Inc.482KUS$12.3M+75,000Sep 30, 2026
Cogent Biosciences, Inc.370KUS$11.9Mno changeSep 30, 2026
ANI Pharmaceuticals, Inc.149KUS$10.8M−123KSep 30, 2026